Greater Cannabis Company, Inc. (GCAND) Change in Accured Expenses (2017 - 2022)
Greater Cannabis Company (GCAND) has 6 years of Change in Accured Expenses data on record, last reported at $40743.0 in Q4 2022.
- For Q4 2022, Change in Accured Expenses rose 5.2% year-over-year to $40743.0; the TTM value through Dec 2022 reached $60000.0, up 17.65%, while the annual FY2024 figure was $22765.0, 74.61% up from the prior year.
- Change in Accured Expenses reached $40743.0 in Q4 2022 per GCAND's latest filing, up from -$743.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $63397.0 in Q4 2019 and bottomed at -$38230.0 in Q3 2019.
- Average Change in Accured Expenses over 5 years is $10517.9, with a median of $7745.5 recorded in 2019.
- The widest YoY moves for Change in Accured Expenses: up 2127.31% in 2018, down 2895.87% in 2018.
- A 5-year view of Change in Accured Expenses shows it stood at $3682.0 in 2018, then surged by 1621.81% to $63397.0 in 2019, then plummeted by 70.4% to $18764.0 in 2020, then soared by 106.4% to $38728.0 in 2021, then grew by 5.2% to $40743.0 in 2022.
- Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $40743.0 in Q4 2022, -$743.0 in Q3 2022, and $13087.0 in Q2 2022.